share_log

4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B

4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B

4:持股变动声明-董事 Ehrlich Christopher B
美股SEC公告 ·  06/13 18:29

Moomoo AI 已提取核心信息

Christopher B Ehrlich, associated with eFFECTOR Therapeutics, Inc. (EFTR), was involved in a transaction on June 13, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, have not been disclosed. Investors are advised to await further information to understand the impact of this event on their investment decisions regarding EFTR stock.
Christopher B Ehrlich, associated with eFFECTOR Therapeutics, Inc. (EFTR), was involved in a transaction on June 13, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, have not been disclosed. Investors are advised to await further information to understand the impact of this event on their investment decisions regarding EFTR stock.
Christopher B Ehrlich与eFFECTOR Therapeutics, Inc.(EFTR)有关,于2024年6月13日参与了一项交易。该交易的具体细节,包括操作类型、状态币、股份数量、股份的性质、交易价格和发帖后的持股情况,尚未披露。投资者应等待进一步信息,以了解此事件对其有关EFTR股票投资决策的影响。
Christopher B Ehrlich与eFFECTOR Therapeutics, Inc.(EFTR)有关,于2024年6月13日参与了一项交易。该交易的具体细节,包括操作类型、状态币、股份数量、股份的性质、交易价格和发帖后的持股情况,尚未披露。投资者应等待进一步信息,以了解此事件对其有关EFTR股票投资决策的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息